“New Avenues for a fruitful biomedical

cooperation between India and the heart of

Europe”

Dr. Philippe Janssens de Varebeke

Life Sciences Expert

Awex
1
Life Sciences in EUROPE

PHARMA

DIAGNOSTIC

MEDICAL DEVICES

EQIPMENT MEDICAUX

SOFTWARE MEDICAUX

SERVICES

BIOLOGISTICS

2
 Life Sciences in EUROPE

• 500 million capita market/ 30% world pharma

Market
• Prestigious International Pharma,diagnostic
and medical equipment companies
• Network of competitive Life Science Clusters
• High level of hospitals
• Excellent education/ Universities

3
 LIFE SCIENCES
PERFORMANCES
BELGIUM as an example

• OECD Study 2005

• Main Conclusions:
1. Belgium N°1 per capita in innovation and industrial development
2. Belgium N°2 per capita scientific publications

• “The Scientist” has elected Belgium as

'Best Country for Academic Research 2007'

• The 7th largest investor in the world in biopharmaceutical R&D,

with over 1.5 billion € annually

4
Life Sciences in Wallonia

1h51

1h20

100 KM

Access to market of 460 Million people in 6 hours

5
 LIFE SCIENCES PERFORMANCES
Belgium-Wallonia (south Brussels)
• 80 Life Sciences Companies
(74% of Belgium)
• 2.9 Billion € Revenues generated in 2007

• 80% in Health Care, 10 000 people

• a High concentration of university hospitals

(30 000 beds)

6
Life Sciences in Wallonia

Academies
100 KM
Science parks 66 Miles

pharma Food

CMO Biotech incubators

Medial Device Environment

Diagnostic Services

7
 Boosting the VALUE CHAIN

ACAD Incub CDO CMO CORP CRO Logistic

You will always find a partner upstream

or downstream
To make your venture successful

The highest density of life sciences employees

in the world

8
 ACAD Incub CDO CMO CORP CRO Logistic

University System
INSTITUTE OF MOLECULAR
BIOLOGY AND MEDICINE (ULB-IBMM)
INSTITUTE OF MEDICAL
IMMUNOLOGY (IMI)
BioVallee

DGTRE
Christian de Duve Institute of Cellular
GIGA Pathology (ICP)
Combined University-Entreprises
Facility for Human & Animal Ludwig Institute for Cancer Research
Genomics & Proteomics Institut des Sciences de la Vie

9
 ACAD Incub CDO CMO CORP CRO Logistic

Prof de Leval

Licence
Production and sales

Medical Device improvement

Female Urinary Incontinence

Patent

Clinical Validation New Element Production

10
 ACAD Incub CDO CMO CORP CRO Logistic

Incubator System

1. (Liège) +

2. Wallonia Biotech S.A.(Gosselies) +

3. (Seneffe) +

4. (LLN) +

11
 ACAD Incub CDO CMO CORP CRO Logistic

has selected Wallonia as its

collaborator for co-location of its best
groundbreaking technologies on the
European soil
Patners:

The A&M System has 103,000 students; 26,000 faculty and staff,
 is present in every Texas county.
Externally funded research brings almost $620 million every year to help drive the
state’s economy.
12
 ACAD Incub CDO CMO CORP CRO Logistic

Transfert of technology Inter

VC
800K€+Superleudox
10M€
Diatos Peptide Vectors Technology (DPV)

2.5M€
License
800K€
Belgium

Superleudox
UCL
Transfert of technology

13
 ACAD Incub CDO CMO CORP CRO Logistic

You will benefit from all the subcontractors of the big corp

14
 ACAD Incub CDO CMO CORP CRO Logistic

ILS NOUS ONT FAIT CONFIANCE !

SPIGA Neochim

15
 Leading Biotech Companies
GSK Biologicals – world leader in vaccines
35 vaccine units/second distributed all over the world
1.1 billion units/year in 169 countries
Total (Belgium) 5,400 (world 8,000)
R&D >1,500 (30%)

UCB – leader in allergy / neurodegenerative diseases

20 years experience in allergy with Zyrtec®
Keppra® (epilepsy): over two million patient years
Total (Belgium) 2,200( world 4,000)
R&D 800 (36%)

IBA – world leader in particle therapy against cancer cells

Proton Therapy : 40.000 patients/year – 22 PT centers
Total (Belgium) 350 ( world 1,800)
R&D 100 (30%)

16
 ACAD Incub CDO CMO CORP CRO Logistic

• The fastest approval for phase 1

clinical trials in EU (2 weeks)
• The highest number of phase 1 trials
in EU per capita
• The largest number of medicines in
development in the World per capita
17
LIFE SCIENCES CLUSTER

Cancer

Inflammation

CNS

18
 Boosting a new culture of openess
and partnership
International visibility

Universities Companies

BioWin
Scientific excellence
Innovation Outstanding Human
Capital
R&D centres
Training centres
Networks

19
19
 The Health Cluster of Wallonia

1. Ambitious R&D projects fostering partnerships between

big pharma, SMEs and Universities In Cancer, inflamation
and Brain diseases granted by WR

2. Creation of activities and Funding new companies

3. Training programmes to attract, retain and develop

outstanding dedicated human capital

20
20
 Current R&D Projects
Powered by BIOWIN
Development and validation of new molecules Cancer – immunotherapy –
allowing to restore the immune response against
cancer cells
drug discovery

Development and validation of a local treatment Cancer – drug delivery

for cervix cancer resulting from human
papillomavirus infection

Discovery of new targets for treatment of the Brain Diseases – drug

Parkinson disease
discovery
Identification of new types of biomarkers and Cancer – inflammation -
tracers for the in vivo molecular imaging
biomarkers

Creation of a technological plateform for the Inflammation – drug

administration of medicines by pulmonary route
delivery – medical device

New tools for the diagnosis of cancer and Cancer - biomarkers

optimization of treatments against cancers
21
21
 CONCLUSIONS
• 1. Strong Network involving Industry and
Universities
• 2. Boosting a new culture of openess and
partnership
• 3. Set up of news companies and new innovative
products for existing companies
• 4. Strengthening of the whole value chain
• 5. Your companies, skilful people, investors are
more than welcome to benefit from those assets
and opportunities

22
FOR FURTHER INFORMATION…

WALLONIA EXPORT AND INVESTMENT AGENCY

FOREIGN DIRECT INVESTMENTS
Namur Office Park
Avenue des dessus de Lives, 6
B-5101 NAMUR

www.investinwallonia.be
Dr. Philippe Janssens de Varebeke
pjanssens@investinwallonia.be

Tel : +32 (0)81 33 28 54

Cell : +32 (0) 496 65 80 87
23